Confirming our hypothesis, neutralizing TGF-β treatment in high-MUC1 HPAFII tumors significantly reduced tumor progression and reduced tumor burden (Figure 5B), whereas the same treatment almost hastened tumor growth in low MUC1 MiaPaca2 tumors (Figure 5B). The gene discussed is TGFB1; the disease is neoplasm.